Iconovo Newsletter 2018

News and inspiration by Iconovo December 2018. Iconovo will be attending DDL2018 in Edinburgh, be sure to sto... Read more

Iconovo at FDA workshop

Iconovo CEO Dr. Orest Lastow took part in an FDA workshop on the evaluation of new methods for characterizing ... Read more

Iconovo News 2017

Iconovo has had a fantastic year. In May, we raised 2.5 million EUR to invest in our formulation development c... Read more


Iconovo is proud to sponsor DDL this year again. We see DDL as the most important meeting for inhaled drug del... Read more

New employee at Iconovo

Mårten Appelgren has joined Iconovo as Director Business Development. Mårten has over 25 years experience from... Read more

New employee at Iconovo

We are very glad to announce that Vesna Åkerberg has joined Iconovo as Director of Pharmaceutical Development.... Read more

Iconovo at RDD in Nice

Iconovo will be joining RDD Europe 2017 in Nice next week. Iconovo's participation was made possible by the ki... Read more

Injection molded ICOcap

The development of Iconovo's proprietary capsule based inhaler, ICOcap has reached an important milestone. The... Read more

New lab facilities

Iconovo has moved into new lab facilities. The new facilities will allow us to perform verification and perfor... Read more

Great interest at DDL

Iconovo was a silver sponsor at DDL 25 in Edinburg, DDL Conference. DDL is the internationally most important ... Read more

Silver sponsor of MVIS

Iconovo is a silver sponsor of MVIS (Medicon Valley Inhalation Symposium) 15 October in Lund. We will exhibit ... Read more